The pandemic has caused many businesses to evaluate emerging risks and adapt to new ways of working. In this seminar, we discuss recent trends within the Life Sciences industry and consider what future collaboration and partnering activity may look like to help you improve business resilience.
This session covers:
- Supply chain localisation
- Restarting clinical trials
- Digitisation
- Remote patient monitoring
- Regulatory developments
Contributor
Grant Strachan
Partner
